Michael Arthur from Wickham Labs explores the challenges pharma professionals face in aseptic processing.
Bacteria
Although we may not realise it, every single person in the world could be affected by the use of sterile products. This may include the use of needles to inject vaccines, administering lifesaving prescription drugs such as Insulin or Epinephrine or in a hopefully rare, but very real situation for 2020, the insertion of a ventilator tube to enable a patient suffering from Covid-19 to breathe.
Many parenteral or sterile products may be produced in a clean but non-sterile environment, then terminally sterilised, however there are also many other parenteral or sterile products for which terminal sterilisation cannot be performed.